A sustained endemic outbreak of vancomycin-resistant Enterococcus faecium: A 30-month surveillance study

Scandinavian Journal of Infectious Diseases

Volumn 46, Issue 8, 2014, Pages 547-554

  Campos, Paola A ^a   Batistão, Deivid W F ^a   Gontijo Filho, Paulo P ^a   Ribas, Rosineide M ^a  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

Author keywords

Colonization pressure; Outbreaks; Vancomycin resistant enterococci

Indexed keywords

AGGREGATION SUBSTANCE 1; AMIKACIN; BACTERIAL PROTEIN; CEFEPIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; ENTEROCOCCAL SURFACE PROTEIN; GELATINASE; GENTAMICIN; METRONIDAZOLE; TEICOPLANIN; TIGECYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; GLYCOPEPTIDE; LIGASE; VANA LIGASE, BACTERIA; VIRULENCE FACTOR;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; COHORT ANALYSIS; DISEASE PREDISPOSITION; DISEASE SURVEILLANCE; ENDEMIC DISEASE; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; EPIDEMIC; FEMALE; FOLLOW UP; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PROSPECTIVE STUDY; PROTEIN ANALYSIS; RISK FACTOR; TERTIARY HEALTH CARE; UNIVERSITY HOSPITAL; VANCOMYCIN RESISTANT ENTEROCOCCUS; AGED; DRUG EFFECTS; EPIDEMIOLOGICAL MONITORING; GENETICS; GRAM-POSITIVE BACTERIAL INFECTIONS; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; TERTIARY CARE CENTER;

AGED; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CARBON-OXYGEN LIGASES; COHORT STUDIES; DISEASE OUTBREAKS; ENDEMIC DISEASES; ENTEROCOCCUS FAECIUM; EPIDEMIOLOGICAL MONITORING; FEMALE; GLYCOPEPTIDES; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INCIDENCE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TERTIARY CARE CENTERS; VANCOMYCIN-RESISTANT ENTEROCOCCI; VIRULENCE FACTORS;

EID: 84904429681     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2014.912348     Document Type: Article

References (34)

1. Cosgrove SE. T he relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 2006 ; 42 : S82-9. (Pubitemid 43054219)
2. Neidell MJ, Cohen B, Furuya Y, Hill J, Jeon CY, Glied S, et al. Costs of healthcare-and community-associated infections with antimicrobial-resistant versus antimicrobialsusceptible organisms. Clin Infect Dis 2012 ; 55 : 807-15.
3. Ribas RM, Darini AL, Moreira TA, Freitas C, Gontijo-Filho PP. Vancomycin-resistant Van A phenotype Enterococcus faecalis: fi rst case in Minas Gerais State and epidemiological considerations . Braz J Infect Dis 2007 ; 11 : 439-40. (Pubitemid 47516803)
4. Batist ão DW, Gontijo-Filho PP, Concei ç ão N, Oliveira AG, Ribas RM. Risk factors for vancomycin-resistant enterococci colonisation in critically ill patients. Mem Inst Oswaldo Cruz 2012 ; 107 : 57-63.
5. Concei ç ão N, Darini AL, Palazzo IC, Oliveira CC, Oliveira AG. First report of vancomycin-resistant Enterococcus faecalis in Uberaba, Minas Gerais State. Braz J Microbiol 2010 ; 41 : 34-6.
6. Pan SC, Wang JT, Chen YC, Chang YY, Chen ML, Chang SC. Incidence of and risk factors for infection or colonization of vancomycin-resistant enterococci in patients in the intensive care unit. PLoS One 2012 ; 7 : e47297.
7. Arias CA, Murray BE. The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol 2012 ; 10 : 266-78.
8. Freitas AR, Tedim AP, Novais C, Ruiz-Garbajosa P, Werner G, Laverde-Gomez JA, et al. Global spread of the hyl(Efm) colonization-virulence gene in megaplasmids of the Enterococcus faecium CC17 polyclonal subcluster. Antimicrob Agents Chemother 2010 ; 54 : 2660-5.
9. Heikens E, Singh KV, Jacques-Palaz KD, van Luit-Asbroek M, Oostdijk EA, Bonten MJ, et al. Contribution of the enterococcal surface protein Esp to pathogenesis of Enterococcus faecium endocarditis. Microbes Infect 2011 ; 13 : 1185-90. Mohamed
10. JA, Huang D B. Biofilm formation by enterococci. J Med Microbiol 2007 ; 56 : 1581-8. (Pubitemid 350276505)
11. Clinical and Laboratory Standards Institute. P erformance standards for antimicrobial susceptibility testing. Twenty-fi rst informational supplement. CLSI document M100-S21. Wayne, PA: CLSI; 2011.
12. Woodford N, Morrison D, Johnson AP, Briant V, George RC, Cookson B. Application of DNA probes for rRNA and van A genes to investigation of a nosocomial cluster of vancomycinresistant enterococci. J Clin Microbiol 1993 ; 31 : 653-8. (Pubitemid 23059883)
13. D utka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identifi cation to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995 ; 33 : 24-7. (Pubitemid 24382391)
14. Vankerckhoven V, Van Autgaerden T, Vael C, Lammens C, Chapelle S, Rossi R, et al. Development of a multiplex PCR for the detection of asa 1, gel E, cyl A, esp, and hyl genes in enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium. J Clin Microbiol 2004 ; 42 : 4473-9. (Pubitemid 39362358)
15. Williams VR, Callery S, Vearncombe M, Simor AE. T he role of colonization pressure in nosocomial transmission of methicillin-resistant Staphylococcus aureus. Am J Infect Control 2009 ; 37 : 106-10.
16. Khanfar H, Senok A, Anani A, Zinkevich V. Methicillinresistant Staphylococcus aureus transmission in a lowprevalence healthcare setting. J Infect Public Health 2012 ; 5 : 311-6.
17. World Health Organization Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classifi cation and DDD assignment 2012. Oslo: WHO ; 2011.
18. Arantes A, Carvalho ES, Medeiros EA, Farhat CK, Mantese OC. Use of statistical process control charts in the epidemiological surveillance of nosocomial infections. Rev Saude Publica 2003 ; 37 : 768-74. (Pubitemid 38094230)
19. Schouten MA, Hoogkamp-Korstanje JA, Meis JF, Voss A ; European VRE Study Group. Prevalence of vancomycinresistant enterococci in Europe. Eur J Clin Microbiol Infect Dis 2000 ; 19 : 816-22.
20. Treitman AN, Yarnold PR, Warren J, Noskin GA. E merging incidence of Enterococcus faecium among hospital isolates (1993 to 2002). J Clin Microbiol 2005 ; 43 : 462-3. (Pubitemid 40096345)
21. Sader HS, Moet GJ, Jones RN. A ntimicrobial resistance among Gram-positive bacteria isolated in Latin American hospitals. J Chemother 2009 ; 21 : 611-20.
22. Panesso D, Reyes J, Rinc ón S, D í az L, Galloway-Peñ a J, Zurita J, et al. Molecular epidemiology of vancomycinresistant Enterococcus faecium: a prospective, multicenter study in South American hospitals. J Clin Microbiol 2010 ; 48 : 1562-9.
23. Sohn KM, Peck KR, Joo EJ, Ha YE, Kang CI, Chung DR, et al. Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital. Int J Infect Dis 2013 ; 17 : e240-6.
24. Furtado GH, Mendes RE, Pignatari AC, Wey SB, Medeiros EA. Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: an analysis of two case-control studies. Am J Infect Control 2006 ; 34 : 447-51. (Pubitemid 46075050)
25. Sakka V, Tsiodras S, Galani L, Antoniadou A, Souli M, Galani I, et al. Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci. Clin Microbiol Infect 2008 ; 14 : 14-21. (Pubitemid 350226565)
26. Puzniak LA, Leet T, Mayfield J, Kollef M, Mundy LM. To gown or not to gown: the effect on acquisition of vancomycin-resistant enterococci. Clin Infect Dis 2002 ; 35 : 18-25. Zirakzadeh (Pubitemid 34666855)
27. Zirakzadeh, A, Patel R. Vancomycin-resistant enterococci: colonization, infection, detection, and treatment. Mayo Clin Proc 2006 ; 81 : 529-36.
28. McGregor JC, Hartung DM, Allen GP, Taplitz RA, Traver R, Tong T, et al. Risk factors associated with linezolidnonsusceptible enterococcal infections. Am J Infect Control 2012 ; 40 : 886-7.
29. Muller A, Mauny F, Talon D, Donnan PT, Harbarth S, Bertrand X. Effect of individual-and group-level antibiotic exposure on MRSA isolation: a multilevel analysis. J Antimicrob Chemother 2006 ; 58 : 878-81. (Pubitemid 44390971)
30. Bonten MJ, Slaughter S, Ambergen AW, Hayden MK, van Voorhis J, Nathan C, et al. The role of " colonization pressure " in the spread of vancomycin-resistant enterococci. Arch Intern Med 1998 ; 158 : 1127-32.
31. Dubberke ER, Reske KA, Olsen MA. Evaluation of Clostridium diffi cile-associated disease pressure as a risk factor for C. diffi cile-associated disease. Arch Intern Med 2007 ; 167 : 1092-7. (Pubitemid 46835798)
32. Borges LF, Kataguiri LG, Nunes MJ, Gontijo-Filho PP. Qualitative and quantitative contamination in hands of health care workers in different units of a Brazilian university hospital. Nursing 2006 ; 8 : 1000-3.
33. Camargo IL, Zanella RC, Gilmore MS, Darini AL. V irulence factors in vancomycin-resistant and vancomycin-susceptible Enterococcus faecalis from Brazil. Braz J Microbiol 2008 ; 39 : 273-8.
34. Ruzon FI, d e Paula SB, Kanoshiki RL, Pereira-Santos J, Kerbauy G, Kobayashi RK, et al. Virulence determinants in vancomycin-resistant Enterococcus faecium van A isolated from different sources at University Hospital of Londrina, Paran á, Brazil. J Microbiol 2010 ; 48 : 814-21.